Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparative Atorvastatin Pleiotropic Effects (CAP)

This study has been completed.
MDS Pharma Services
Bio-Inova Life Sciences International
Information provided by:
Pfizer Identifier:
First received: September 9, 2005
Last updated: March 14, 2008
Last verified: April 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):